tiprankstipranks

Oruka Therapeutics initiated with an Outperform at LifeSci Capital

LifeSci Capital initiated coverage of Oruka Therapeutics with an Outperform rating and $41 price target.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue